190 related articles for article (PubMed ID: 1804785)
1. Quinolones in the treatment of lower respiratory tract infections caused by intracellular pathogens.
Chidiac C; Mouton Y
Infection; 1991; 19 Suppl 7():S365-71. PubMed ID: 1804785
[TBL] [Abstract][Full Text] [Related]
2. [Value of quinolones in the treatment of lower respiratory tract infections caused by intracellular organisms, excluding mycobacteria].
Chidiac C; Senneville E; Mouton Y
Pathol Biol (Paris); 1992 Jun; 40(6):638-45. PubMed ID: 1408383
[TBL] [Abstract][Full Text] [Related]
3. Incidence of lower respiratory tract infections caused by Mycoplasma, Chlamydia and Legionella: an Italian Multicenter Survey.
Schito GC; Grazi G; Dainelli B; Càtamo G; Satta G; Grillo RL; Stefani S; Russo G
J Chemother; 1994 Oct; 6(5):319-21. PubMed ID: 7861196
[TBL] [Abstract][Full Text] [Related]
4. Treatment of lower respiratory infections in outpatients with ofloxacin compared with erythromycin.
Peugeot RL; Lipsky BA; Hooton TM; Pecoraro RE
Drugs Exp Clin Res; 1991; 17(5):253-7. PubMed ID: 1756688
[TBL] [Abstract][Full Text] [Related]
5. Quinolones in the treatment of lower respiratory tract infections.
Thys JP; Jacobs F; Motte S
Rev Infect Dis; 1989; 11 Suppl 5():S1212-9. PubMed ID: 2672250
[TBL] [Abstract][Full Text] [Related]
6. [Emergent pneumonias].
Croce GF; Mazzei L; Mancini P
G Clin Med; 1989 Oct; 70(10):605-13. PubMed ID: 2689257
[No Abstract] [Full Text] [Related]
7. [Incidence, diagnosis and therapy of acute respiratory tract diseases caused by influenza viruses, Mycoplasma, Legionella and Chlamydia].
Wagner K; Dux K; Marquart A
Z Gesamte Inn Med; 1987 Jun; 42(11):307-10. PubMed ID: 3660885
[TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolones in respiratory infections.
Klein NC
Semin Respir Infect; 1991 Sep; 6(3):131-5. PubMed ID: 1754733
[TBL] [Abstract][Full Text] [Related]
9. New macrolides or new quinolones as monotherapy for patients with community-acquired pneumonia: our cup runneth over?
Yu VL; Vergis EN
Chest; 1998 May; 113(5):1158-9. PubMed ID: 9596286
[No Abstract] [Full Text] [Related]
10. Atypical pathogens and respiratory tract infections.
Blasi F
Eur Respir J; 2004 Jul; 24(1):171-81. PubMed ID: 15293621
[TBL] [Abstract][Full Text] [Related]
11. The problems of treating atypical pneumonia.
Schlick W
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():111-20. PubMed ID: 8478302
[TBL] [Abstract][Full Text] [Related]
12. Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
Thys JP; Jacobs F; Byl B
Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):304-15. PubMed ID: 1864291
[TBL] [Abstract][Full Text] [Related]
13. Chlamydial infections and the quinolones.
Ronald AR; Peeling RW
Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):351-4. PubMed ID: 1864296
[TBL] [Abstract][Full Text] [Related]
14. The place of quinolones in the treatment of respiratory tract infections.
van der Meer JW
Pharm Weekbl Sci; 1989 Aug; 11(4):132-3. PubMed ID: 2677985
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of pneumonia caused by Legionella, Mycoplasma, Chlamydiae and Rickettsia using ofloxacin].
Leroy O; Beuscart C; Chidiac C; Sivery B; Senneville E; Vincent du Laurier M; Mouton Y
Pathol Biol (Paris); 1989 Dec; 37(10):1137-40. PubMed ID: 2691969
[TBL] [Abstract][Full Text] [Related]
16. [Legionellosis (Legionnaires' disease, Pontiac fever)].
Tateyama M; Saito A
Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):11-4. PubMed ID: 10088325
[No Abstract] [Full Text] [Related]
17. The role of new quinolones in the treatment of respiratory tract infections.
Finch RG
Drugs; 1995; 49 Suppl 2():144-51. PubMed ID: 8549285
[TBL] [Abstract][Full Text] [Related]
18. Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.
Spivey IM
Clin Pharm; 1993 Jun; 12(6):452-8. PubMed ID: 8403817
[No Abstract] [Full Text] [Related]
19. [Ambulant atypical pneumonia: clinical diagnosis and therapy].
Schaberg T; Lode H
Immun Infekt; 1992 Aug; 20(4):136-7. PubMed ID: 1398735
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
Appelbaum PC; Gillespie SH; Burley CJ; Tillotson GS
Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
